NASDAQ:SOPH SOPHiA GENETICS (SOPH) Stock Price, News & Analysis $8.07 -0.17 (-2.06%) Closing price 04:00 PM EasternExtended Trading$8.06 -0.01 (-0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About SOPHiA GENETICS Stock (NASDAQ:SOPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SOPHiA GENETICS alerts:Sign Up Key Stats Today's Range$8.04▼$8.5150-Day Range$5.55▼$8.9252-Week Range$3.37▼$8.98Volume566,495 shsAverage Volume287,995 shsMarket Capitalization$676.99 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingHold Company Overview SOPHiA GENETICS Ltd. is a healthcare technology company that develops data-driven medicine solutions for healthcare institutions, pharmaceutical companies and research organizations. The company’s platform is designed to help users analyze complex genomic and multimodal data and apply insights to clinical research and patient care. Its core offering, the SOPHiA DDM platform, combines cloud-based software, artificial intelligence and machine-learning tools to support the interpretation of genomic data. The platform is used in areas including oncology, hereditary diseases and other clinical applications, helping laboratories manage workflows, identify relevant genetic variants and generate clinically actionable information. Founded in 2011 and headquartered in Rolle, Switzerland, SOPHiA GENETICS serves a global network of healthcare and life sciences organizations. The company operates internationally through collaborations with hospitals, laboratories, pharmaceutical companies and research institutions. It became a publicly traded company on the Nasdaq in 2021.AI Generated. May Contain Errors. Read More SOPHiA GENETICS Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks55th Percentile Overall ScoreSOPH MarketRank™: SOPHiA GENETICS scored higher than 55% of companies evaluated by MarketBeat, and ranked 383rd out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingHold Consensus RatingSOPHiA GENETICS has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialSOPHiA GENETICS has a consensus price target of $10.00, representing about 22.7% upside from its current price of $8.15.Amount of Analyst CoverageSOPHiA GENETICS has only been the subject of 4 research reports in the past 90 days.Read more about SOPHiA GENETICS's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SOPHiA GENETICS are expected to grow in the coming year, from ($0.77) to ($0.31) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SOPHiA GENETICS is -7.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SOPHiA GENETICS is -7.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSOPHiA GENETICS has a P/B Ratio of 11.81. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about SOPHiA GENETICS's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.38% of the float of SOPHiA GENETICS has been sold short.Short Interest Ratio / Days to CoverSOPHiA GENETICS has a short interest ratio ("days to cover") of 1.92, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SOPHiA GENETICS has recently increased by 18.53%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSOPHiA GENETICS does not currently pay a dividend.Dividend GrowthSOPHiA GENETICS does not have a long track record of dividend growth. News and Social Media1.6 / 5News Sentiment0.51 News SentimentSOPHiA GENETICS has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for SOPHiA GENETICS this week, compared to 5 articles on an average week.MarketBeat FollowsOnly 2 people have added SOPHiA GENETICS to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership1.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, SOPHiA GENETICS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,317,759.00 in company stock.Percentage Held by Insiders4.88% of the stock of SOPHiA GENETICS is held by insiders.Percentage Held by Institutions31.59% of the stock of SOPHiA GENETICS is held by institutions.Read more about SOPHiA GENETICS's insider trading history. Receive SOPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SOPH Stock News HeadlinesSOPHiA GENETICS SA (SOPH)September 18, 2026 | finance.yahoo.comSOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization InflectSeptember 16, 2026 | seekingalpha.comCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial technology framework in US history. JPMorgan, Citi, Bank of America and Wells Fargo are building a shared next generation payment network targeting 2027, and the DTCC just completed its first live production trades on the new system. Senior analyst Andy Howard breaks down the asset at the center of this shift in a free report.September 22 at 1:00 AM | Awesomely (Ad)Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) StockSeptember 16, 2026 | americanbankingnews.comWell Daan Van Sells 6,168 Shares of SOPHiA GENETICS (NASDAQ:SOPH) StockSeptember 15, 2026 | insidertrades.comSOPHiA GENETICS (NASDAQ:SOPH) Director Sells 6,250 Shares of StockSeptember 11, 2026 | insidertrades.comSOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares of StockSeptember 1, 2026 | insidertrades.comWhen Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals (SOPH)Canada Goose, Capital Clean Energy Carriers and SOPHiA Genetics have each seen unusual trading volume recently, driven by tariffs, LNG demand, and a strong earnings beat, respectively.August 28, 2026 | marketbeat.comSee More Headlines SOPH Stock Analysis - Frequently Asked Questions How have SOPH shares performed this year? SOPHiA GENETICS's stock was trading at $4.67 at the beginning of 2026. Since then, SOPH shares have increased by 74.5% and is now trading at $8.15. How were SOPHiA GENETICS's earnings last quarter? SOPHiA GENETICS SA (NASDAQ:SOPH) posted its earnings results on Wednesday, August, 5th. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.05. The firm earned $23.31 million during the quarter, compared to the consensus estimate of $21.72 million. SOPHiA GENETICS had a negative trailing twelve-month return on equity of 132.47% and a negative net margin of 93.86%. Read the conference call transcript. When did SOPHiA GENETICS IPO? SOPHiA GENETICS (SOPH) raised $234 million in an IPO on Wednesday, July 21st 2021. The company issued 13,000,000 shares at $17.00-$19.00 per share. Who are SOPHiA GENETICS's major shareholders? Top institutional investors of SOPHiA GENETICS include AWM Investment Company Inc. (2.03%), Maven Securities LTD (0.18%), Hennion & Walsh Asset Management Inc. (0.12%) and AXQ Capital LP (0.02%). Insiders that own company stock include Jurgi Camblong, Ross Muken, Zhenyu Xu, Well Daan Van, George Cardoza, Philippe Menu, Manuela Valente, Abhimanyu Verma, Kevin Puylaert and Kathy L Hibbs. View institutional ownership trends. How do I buy shares of SOPHiA GENETICS? Shares of SOPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SOPHiA GENETICS own? Based on aggregate information from My MarketBeat watchlists, some other companies that SOPHiA GENETICS investors own include Occidental Petroleum (OXY), PayPal (PYPL), Cheniere Energy (LNG), Rocket Pharmaceuticals (RCKT), AbCellera Biologics (ABCL) and Farmers & Merchants Bancorp (FMAO). Company Calendar Last Earnings8/05/2026Today9/22/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (12m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 SOPH's financial health is in the Green zone, according to TradeSmith. SOPH has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:SOPH CIK1840706 Webwww.sophiagenetics.com Phone41-21-694-1060FaxN/AEmployees415Year Founded2011Price Target and Rating Average Price Target for SOPHiA GENETICS$10.00 High Price Target$14.00 Low Price Target$7.00 Potential Upside/Downside+23.9%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($1.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$79 million Net Margins-93.86% Pretax Margin-93.19% Return on Equity-132.47% Return on Assets-45.97% Debt Debt-to-Equity Ratio0.58 Current Ratio2.69 Quick Ratio2.55 Sales & Book Value Annual Sales$77.27 million Price / Sales8.76 Cash FlowN/A Price / Cash FlowN/A Book Value$0.69 per share Price / Book11.69Miscellaneous Outstanding Shares83,890,000Free Float79,801,000Market Cap$676.91 million OptionableNot Optionable Beta0.98 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:SOPH) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just cleared regulatory approval to begin a Phase II trial of NV-387 Oral Gummies f...Equiscreen | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
